What This Company Is

Helios Technologies makes engineered hydraulic components and ruggedized electronic controls. Two segments: Hydraulics (64% of $839M FY2025 revenue) makes screw-in cartridge valves, manifolds, and quick-release couplings. Electronics (36%) makes spa/hot tub controls, rugged displays for marine and powersports, and industrial instrumentation. The products are designed into customer equipment — once a Sun valve or Enovation display is specified in an OEM's product line, it stays until the model is redesigned. This is a sticky, mission-critical component business, not a commodity manufacturer.

Four flagship brands built through acquisition: Sun Hydraulics (valves, the original 1970 franchise), Faster (Italian couplings, acquired 2019), Balboa Water Group (spa controls, 2019), and Enovation Controls (rugged displays, 2021). Manufacturing in 10 countries. No single customer exceeds 10% of revenue. Channel is ≈55% distributor / 45% OEM in Hydraulics, reverse in Electronics (78% OEM direct).

The company spent $211M on five acquisitions in 2022-2023, then the CEO was terminated for cause in July 2024 and everything pivoted: zero acquisitions, aggressive deleveraging, portfolio rationalization, and a cultural shift from "fishing" (passive order-taking) to "hunting" (targeted go-to-market). FY2025 was the inflection year — first revenue growth in three years, record cash flow, four consecutive earnings beats.


The Financial Story

The Trough-to-Recovery Arc

Revenue peaked at $885M in FY2022 on pandemic tailwinds. Post-pandemic normalization crushed marine, spa, and industrial demand — revenue fell 9% over two years to $806M by FY2024. FY2025 marked the turn: $839M (+4.1%), with Hydraulics growing +0.7% while US hydraulic shipments (NFPA) declined 4% — roughly 470bps of outperformance, though the comparison is imprecise since NFPA measures US shipments only and HLIO Hydraulics is 60% non-Americas. Electronics up 11%.

The P&L tells a cleaner story than the headline:

FY2022 (Peak)FY2024 (Trough)FY2025 (Inflection)FY2026E (Guide Mid)
Revenue$885M$806M$839M$840M
Gross Margin33.7%31.3%32.3% (Q4: 33.6%)≈34% implied
Adj EBITDA≈$190M est≈$155M est$161M (19.2%)$170M (20.25%)
Adj EPS≈$3.50 est$2.10$2.56$2.75 (guide mid)
Net Debt/EBITDA≈2.0x≈2.6x1.8x≈1.4x est
Interest Expense, net≈$16M$33.8M$21.9M*≈$17-19M est
FCF$78M$95M$104M≈$110M est

*The $21.9M is NET of a $5.4M one-time interest rate swap benefit reclassified from OCI (10-K MD&A, line 2424). Gross credit agreement interest was ≈$27.0M (10-K Note 10, line 4178). Three factors drove the $11.9M YoY decline: lower average debt ($349.8M avg vs $448.9M prior year), lower rates, and the $5.4M swap gain. FY2026 estimate of $17-19M reflects continued debt paydown (year-end gross debt $367M declining ≈$15-22M/quarter at 5.0% effective rate).

Where the Cash Goes

This is a genuine FCF machine. D&A ($63M) runs 2.7x CapEx ($24M), meaning reported earnings significantly understate cash generation. CapEx intensity at 2.8% of revenue is low for a manufacturer. The company generated $104M of FCF on $839M revenue (12.3% FCF margin) and deployed it:

  • Debt paydown: ≈$95M net (bringing leverage from 2.6x to 1.8x)
  • CFP divestiture proceeds: $47M (portfolio optimization)
  • Buybacks: $14M — first-ever share repurchase program
  • Dividends: $12M ($0.36/share, 116 consecutive quarters / 29 years)
  • CapEx: $24M (down from $34M two years ago)

Available liquidity now exceeds total debt: $394M undrawn revolver + $400M accordion vs $367M gross debt. The balance sheet is transitioning from leveraged acquirer to investment-grade profile.

The Intangible Drag — And Its Tailwind

$31.7M of annual intangible amortization from M&A gets allocated to Corporate and excluded from segment operating income. This is why segment margins (Hydraulics 16.9%, Electronics 11.9% ex-impairment) look reasonable but consolidated GAAP margins (7.9%) look anemic. The amortization schedule: $30.5M in 2026, declining to $25.3M by 2029. As this burns off, GAAP and non-GAAP converge — worth ≈$0.12/share per year in after-tax earnings improvement, mechanically.

Goodwill of $498M is 33% of total assets ($868M including intangibles = 57% of assets). This is the legacy of the 2019-2023 acquisition spree. i3PD was already written down to zero ($25.9M). The remaining goodwill is tested qualitatively — the 10-K does NOT disclose margin of safety above carrying value for any reporting unit. This is a gap in disclosure that warrants attention.


Competitive Position: B+

HLIO occupies defensible niches inside much larger markets. In hydraulics, Parker Hannifin ($85B market cap) and Danfoss/Eaton dominate the system-level business, but Sun Hydraulics' floating-nose cartridge valve technology has a 55-year engineering heritage and operates at higher pressures than most competitors. The products are specified into OEM designs for 10+ year model cycles. "If that goes down, that whole piece of equipment goes down" — CEO Bagan on component criticality.

The competitive landscape breaks into tiers:

Strong moat: Sun cartridge valve technology (proprietary design, 55-year heritage), Balboa spa controls (de facto industry standard, USMCA-compliant Tijuana manufacturing), design-in switching costs across both segments.

Moderate moat: Enovation's hardware+software integration (custom displays with proprietary firmware), Faster's agriculture coupling franchise (AGCO confirmed as customer — Fendt, Valtra, Massey Ferguson commonizing on Faster couplings).

Weak moat: Standard couplings (face Chinese copycat competition), basic electronic displays without software differentiation.

The tariff environment is currently a tailwind: 145% tariffs on Chinese imports make copycat valve and coupling producers uncompetitive in the US market. Management frames this as offensive — "We've seen some wins already in the coupling business where there are US operations but rely on Chinese manufacturing." This is real but fragile — the 10-K explicitly references "recent federal court decisions invalidating certain previously announced tariffs" and the IEEPA legal challenge. If tariffs are reversed or reduced, the competitive moat against Chinese copycats narrows immediately, and share gains attributed to tariff dislocation may prove temporary. The $15M gross tariff cost headwind would also disappear, but the competitive benefit is larger than the cost headwind.

What competitors and industry data say: Parker raised its off-highway outlook from negative to "neutral to positive low single digits" for FY2026 (January 2026 call). HLIO is guiding Hydraulics +5% pro forma — outgrowth above the industry leader implies share gains are required, not just market recovery. IDEX Fire & Safety (Enovation's 15-year partner for fire apparatus displays) reported record orders and four consecutive quarters of organic growth — healthy end-market confirmation but IDEX never mentions HLIO in seven transcripts, suggesting Enovation is one of several suppliers, not sole-source.

One contradicting data point the memo must address: the CEMA Business Barometer (December 2025, cited in HLIO's own 10-K at lines 2092-2103) reports that "the majority of survey participants expect incoming orders to decline in the coming six months" for European agricultural machinery. Tractor and harvester manufacturers "see a deterioration in the current situation." This directly challenges the "ag stabilization" narrative. CEMA does note that export business outside the EU has improved for three months and that Australia/New Zealand are growth areas — so the picture is mixed, not uniformly negative. But European ag, where Faster has its strongest position, faces continued headwinds. Management's "ag stabilized with H2 growth" framing applies to North America; European ag is a different story.


Management & Governance: B-

The governance structure works. When the board discovered the prior CEO violated the Code of Conduct, they terminated him for cause within four weeks — no severance, no bonus, all equity forfeited. They appointed Bagan as interim CEO the same week. The company didn't miss a beat operationally. The compensation structure correctly penalized multi-year underperformance: 2022-2024 performance equity paid 0% at corporate and Electronics, 31% at Hydraulics. Executives didn't get paid when they didn't perform.

The governance execution has stumbled. The C-suite timeline since July 2024:

  • Jul 2024: CEO Matosevic terminated for cause
  • Jan 2025: CFO Bagan promoted to CEO (retaining CFO duties)
  • Mar 2025: Electronics President Wichlacz separated
  • Oct 2025: New CFO Connaway starts
  • Nov 2025: Connaway departs after 35 days
  • Nov 2025: CAO Evans promoted to CFO

Three effective CFO transitions in twelve months is abnormal for a $2.2B public company. The Connaway episode — hired, relocated, and separated in 35 days — is unexplained beyond the required disclaimer that it was "not related to accounting practices, financial statements, internal controls or operations." This language is legally mandated when true; it tells you nothing about the actual reason.

Insider ownership is negligible: all directors and officers combined own 0.6% of shares (180,270 shares). CEO Bagan owns $569K worth — less than his base salary. Zero open market purchases by any insider in recent history. Wasatch Advisors, the largest holder at 10.6%, has been selling (reduced from 3.8M shares to 2.6M sole power between Feb 2024 and Feb 2025).

The saving grace: the business ran through all of this. Four consecutive earnings beats, record cash flow, $50M+ in new business wins. The operating layer — segment presidents Arduini (Hydraulics EMEA), Martich (Hydraulics Americas), and Aldridge (Electronics) — appears stable and competent. The operational thesis doesn't depend on C-suite brilliance; it depends on the business model and the middle management executing the "fishing to hunting" go-to-market shift.

One additional governance dimension: the unnamed "recreational customer" driving outsized Electronics growth is described by Bagan as being in "side-by-side ATVs, snowmobiles, motorcycles" — which is precisely Polaris's product portfolio, where Bagan spent 23 years before joining Helios. This is not a related-party transaction in the legal sense (Bagan has no disclosed ongoing financial interest in Polaris), but a CEO whose former employer of two decades is plausibly the largest single customer in one of his two business segments creates a perception risk. Institutional investors with governance screens would note this. The 10-K's related party transactions note (Note 17) shows zero related party activity in FY2025 — but Polaris would not appear there unless a director had a direct interest.

In February 2026, the board doubled Bagan's severance from 12 to 24 months. This is either a retention signal (the board wants to lock him in) or a negotiating outcome (Bagan wanted protection given the governance track record). Either way, it suggests the board views the current leadership as stable.


Factor Profile: 60% Company / 40% Factor

HLIO's return variance breaks down as:

FactorBetaVariance ContributionEdge?
IWM (small-cap)+1.2131.7%Partial — speed advantage in thin coverage
XLI (industrials)+0.7915.9%Partial — transcript cross-referencing
VLUE (value)+0.5712.0%No
MTUM (anti-momentum)-0.61-11.0%No
SPY (market)-0.42-7.3%No
Idiosyncratic58.7%Yes — company thesis

Idiosyncratic variance: 59% — below the 75% target. This is not a pure stock pick. Roughly 40% of returns are driven by small-cap risk appetite, industrial cycle positioning, and value factor rotation.

For comparison: Parker Hannifin is 29% idiosyncratic (it IS the industrials index). IDEX is 43.5% idio with negative alpha (destroying value vs factors). HLIO at 59% idio with +17-27% trailing alpha has substantially more standalone character than either peer — the recovery from trough, management turnaround, and margin inflection are genuinely orthogonal to factors.

The negative momentum loading (beta -0.61) is notable. HLIO moves opposite to the momentum factor — it outperforms when momentum stocks underperform. This makes it a natural portfolio hedge against momentum crowding.

The -11.8% weekly decline and RSI 28.6 are partially factor-driven. With IWM beta of 1.21, a broad small-cap de-risking episode mechanically hits HLIO harder than its fundamentals warrant. Some of the current sell-off is HLIO-specific (tariff uncertainty, governance discount), but a meaningful portion is small-cap factor contagion.

Edge% for sizing: 59% (conservative, idio component only).


Forward Expectations Gap

What $65.58 Requires

The current multiple remains discounted to peers despite strong recent execution. At 14.5x forward EV/EBITDA, the stock implies roughly the low end of FY2026 guidance:

EV = $2.46B
At 15x forward EV/EBITDA → implied EBITDA = $164M → margin = 19.5%
→ Exactly the LOW END of 19.5-21.0% guided range

For context, niche industrial peers (IEX, NDSN) trade at 17-20x EV/EBITDA. HLIO's 14.5x represents a 20-30% discount. The discount is partially justified — 20% EBITDA margins vs peers at 25-35%, governance risk (3 CFO transitions), smaller cap with thin coverage (6 analysts), and an M&A-heavy balance sheet (57% goodwill + intangibles). A stock that has rallied 80% in 12 months with 6 unanimous Buy ratings is not a neglected or forgotten name — the recovery is well-known. The question is whether the remaining discount is too wide given the quality of recent execution, or whether it accurately reflects structural quality differences.

The Big EPS Gap

SourceFY2026 Adj EPS
Management guide (low)$2.60
Management guide (mid)$2.75
Management guide (high)$2.90
Street consensus (implied by fwd P/E)$3.20

The street is 16% above the midpoint of guidance. Four consecutive beats averaging 15.4% have trained the sell-side to look through guidance. This creates a binary setup: either the beat cadence continues (validating $3.20) or it stops (resetting expectations lower).

The FY2025 base is also inflated by two items consensus may not fully adjust for:

  1. 53-week fiscal year — Extra week added ≈$16M (1.9%) to FY2025 revenue. FY2026 is 52 weeks. Growth comparisons are easier than they appear.
  2. $5.4M one-time interest rate swap benefit — Flatters FY2025 EPS by ≈$0.12. Underlying FY2026 growth is 15-17%, not the headline 7%.

Three Non-Consensus Divergences

1. Brunswick vs HLIO on marine (upside risk)

Brunswick (Q4 2025 call, Jan 29): "Retail up double digits so far in January... healthiest dealer pipelines in years... boat order book at 79% of first wholesale forecast, up 13 percentage points."

HLIO (Q4 2025 call, Mar 3): "Not expecting significant growth" from marine.

If Brunswick's marine optimism proves correct, Enovation Controls marine display business (≈15-20% of Electronics, roughly $50-60M) outperforms management's guide. However, Bagan's conservative marine guidance likely reflects HLIO's own order book visibility, which is more relevant than Brunswick's market-level commentary. And the "one specific customer" driving Electronics growth is in powersports/off-road, not marine — so the marine contribution is secondary to the Enovation growth story. Potential upside, but smaller than the framing suggests.

2. Chip cost 4-5x escalation (downside risk)

Bagan on Q4 call: "Prices on certain chips up four to five times... chip manufacturers moving to high-end chips. Potentially going to face constrained supply."

The key word is "certain" — this likely refers to specific legacy/commodity memory chips being crowded out by AI demand, not all electronic components across the board. If affected chips represent 5-10% of Electronics COGS (≈$10-20M), a 4-5x price increase on that subset translates to a $30-80M gross cost increase pre-mitigation, partially offset by pricing pass-through. The $6-9M EBITDA headwind estimate assumes significant pass-through works. If it doesn't, the impact is larger. This is management commentary (0.75 credibility) — the 10-K does not mention chip pricing specifically. The company pre-built chip inventory for 2026 (elevated inventory noted on the call), but this protection expires in H2. Simultaneously, the Tijuana manufacturing transfer (the primary cost-reduction initiative for Electronics) has been paused due to tariff uncertainty. Two margin levers moving in the wrong direction.

3. Single customer concentration in Electronics (structural risk)

Analyst Tarantino (Q4 call) asked whether Electronics growth is "driven by recent tailwinds from one specific customer." Bagan confirmed: "The one customer that we highlighted is really taking a lot of share, and we are benefiting from that."

While no customer exceeds 10% of consolidated sales, one unnamed recreational OEM could represent 20-30% of the Electronics segment ($60-90M). If their share gains plateau or reverse, Enovation's growth trajectory decelerates materially. This dependency is under-modeled because analysts tend to extrapolate segment-level growth rates without disaggregating single-customer contribution.

Q1 Run Rate vs Full Year

Q1 2026 guide: $218-223M (midpoint $220.5M). Annualized = $882M. Full-year guide midpoint = $840M. The $42M gap implies either genuine H2 deceleration or management building buffer. CFO Evans confirmed: "Much stronger year-over-year growth rates first half." Given the systematic beat pattern, $850-860M is more likely than $840M.

Options Market Signal

March 20 options expire on the same day as the Investor Day. The options market is pricing an ±8.8% implied move ($59.80 to $71.40). Call open interest is 3.2x puts (bullish longer-term positioning), but put volume on March 9 was 3.65x calls (active hedging). Max pain at $55 — 16% below current. Put implied volatility exceeds call IV by 12.9 percentage points, an unusual skew indicating elevated downside fear into the event.


Key Risks

1. Management stability (high probability, moderate impact) Three CFO transitions in twelve months. Connaway's 35-day tenure remains unexplained. Bagan is untested as CEO with 14 months tenure and minimal insider ownership ($569K). Governance screens at institutional investors may cap the multiple until the team demonstrates multi-year continuity.

2. Tariff regime uncertainty (high probability, wide impact range) The 10-K names IEEPA specifically and references "recent federal court decisions invalidating certain previously announced tariffs." US exports of $133M (16% of sales) and China at 11% of revenue create direct exposure. Tariffs are simultaneously a tailwind (Chinese copycats priced out) and a headwind ($15M gross cost, supply chain disruption). The Tijuana manufacturing pause is a direct consequence — a key margin improvement initiative frozen indefinitely.

3. Goodwill concentration (low probability, high impact) $498M of goodwill (33% of assets) with only qualitative impairment testing disclosed. i3PD's full write-off in 2.5 years demonstrates impairment risk is real, not hypothetical. If end markets deteriorate meaningfully, the Electronics reporting unit (≈$160M net goodwill from Balboa + Enovation + others) is most exposed.

4. Single customer dependency (moderate probability, moderate impact) One unnamed recreational OEM is driving outsized Electronics growth. Customer concentration that doesn't breach the 10% consolidated disclosure threshold can still create segment-level vulnerability. If this customer's share gains reverse, the Electronics growth narrative breaks.

5. Chip supply and cost (moderate probability, moderate impact) Memory chip prices up 4-5x as AI demand crowds out commodity chips. Pre-built inventory protects 2026 but creates H2/FY2027 exposure. Pricing pass-through is management's stated mitigation but hasn't been tested against customer resistance.

6. Factor exposure (high probability, moderate impact) At 59% idiosyncratic, 41% of returns are factor-driven. IWM beta of 1.21 means a 10% small-cap selloff translates to 12% HLIO drawdown regardless of fundamentals. The current RSI 28.6 partially reflects this dynamic. In a portfolio context, this position adds meaningful small-cap and industrial beta — not just company-specific alpha.

7. Electronics underinvestment (moderate probability, moderate impact) Electronics CapEx was halved from $8.6M (FY2023) to $4.3M (FY2025) even as the segment is positioned as the growth engine (+11% FY2025, +7% guided FY2026). The Tijuana pause explains part of this, but if growth accelerates and capacity constraints bind, the underinvestment becomes a bottleneck.

8. European ag deterioration (moderate probability, moderate impact) CEMA Business Barometer (December 2025, cited in HLIO's 10-K) reports European ag machinery manufacturers expect declining incoming orders over the next six months. Faster's European coupling franchise is directly exposed. Management's "ag stabilization" framing applies primarily to North America; European ag is a different and weaker story.


What to Watch

March 20, 2026: Investor Day (CORE 2030 Strategy) This is the near-term catalyst. First Investor Day under Bagan. The market expects: long-term financial targets, M&A framework with $394M+ of available firepower, product pipeline detail, and a credible multi-year vision. If Bagan articulates a compelling path to mid-20s EBITDA margins and $1B+ revenue, the governance discount narrows. If the presentation is vague or underwhelming, the discount persists.

May 7, 2026: Q1 Earnings The test of whether the beat cadence continues. Consensus Q1 EPS ≈$0.69 vs management guide $0.65-0.70. Street expects beat #5. The more important number is the order book commentary — "sustained order volumes for the last ten months" (Q4 call) either extends to 14+ months or breaks the trend. Watch H2 guide language — does management tighten the full-year range upward?

Chip cost pass-through Monitor Electronics segment gross margin in Q1/Q2. If 33%+ holds despite 4-5x chip cost inflation, pricing power is confirmed. If margin compresses toward 30-31%, the headwind is real and consensus EPS is too high.

Marine recovery Brunswick reports Q1 on April 24. If marine retail demand confirms the "double-digit January" trajectory, HLIO's Enovation marine business is tracking above guide. Watch for management to mention this on Q1 call.

CFO search / insider buying The company is still searching for a permanent CFO (Evans is promoted from CAO as interim solution). Naming a credible external CFO would reduce governance discount. Any open market purchase by Bagan would be a meaningful signal — zero code P transactions to date.

Wasatch Advisors positioning Largest holder at 10.6%, but sold ≈1.3M shares during 2024. Next 13F filing (May 2026) reveals whether they continued selling into the rally or stabilized. Active small-cap specialist selling during recovery is a negative signal.


LR Signal: 1.3

The multiple discount to peers (14.5x vs 17-20x) is wider than the fundamental quality gap warrants, given four consecutive beats and record FCF. But 80% of the recovery is already priced — the stock was $36 twelve months ago. What remains is whether the NEXT leg of margin expansion and revenue growth materializes, and the evidence is genuinely mixed.

The strongest bull evidence: four consecutive beats despite management churn, record cash flow, FCF conversion well above earnings, and a balance sheet that has healed from 3.0x to 1.8x leverage. The peer discount is too steep for a company executing this well. The strongest bear evidence: zero insider buying, largest institutional holder actively selling, 3 CFO transitions in 12 months, chip cost escalation removing one margin lever, Tijuana pause removing another, single customer concentration in Electronics, and 41% of returns driven by factors — not company-specific insight. European ag data (CEMA) contradicts the stabilization narrative for Faster's core market.

LR 1.3 (not 1.5) because: (a) the stock has already repriced most of the recovery, (b) the governance discount is at least partially warranted and won't resolve quickly, (c) the factor exposure at 41% means a meaningful portion of any thesis is "buy small-cap industrials" rather than HLIO-specific insight, and (d) the non-consensus findings cut both ways — marine upside and chip cost downside roughly offset. The gap is real but narrow. Execution through Q1-Q2 2026 and the March 20 Investor Day will determine whether it widens or closes.

This is an initiation of coverage, not a trade recommendation. Alpha calculation and position sizing require the Investor Day outcome and Q1 results to resolve key uncertainties (margin trajectory, strategic direction, management credibility).


Evidence

EvidenceSourceCredibilityLR
Q4 revenue $211M, +17% YoY; gross margin 33.6%, +350bps8-K 2026-03-02, Exhibit 99.10.951.6
FY2026 guide: $820-860M revenue, 19.5-21% EBITDA margin8-K 2026-03-02, earnings release0.951.2
Q1 guide $218-223M annualizes to $882M vs $840M full-year midpoint8-K 2026-03-020.951.5
4 consecutive EPS beats averaging 15.4% (Q1-Q4 2025)yfinance earnings history0.951.7
53-week fiscal year inflates FY2025 revenue by ≈$16M (1.9%)10-K 2026-03-03, Note 20.950.8
$5.4M one-time interest rate swap benefit in Q4 FY20258-K 2026-03-02, earnings release0.950.8
CEO Bagan: "Prices on certain chips up four to five times"Q4 2025 transcript, line ≈1340.750.6
Tijuana manufacturing transfer "paused" due to tariff uncertainty10-K 2026-03-03, restructuring section0.950.7
CEO Bagan: "One customer really taking a lot of share, we are benefiting"Q4 2025 transcript, line ≈940.750.7
Brunswick: "Retail up double digits so far in January"BC Q4 2025 transcript, line ≈1410.801.8
Parker: Off-highway raised to "neutral to positive low single digits"PH Q2 FY2026 transcript, line ≈490.851.3
Net debt/EBITDA 1.8x, down from 3.0x in ≈18 months10-K 2026-03-03, debt notes0.951.4
FCF $104M (12.3% margin), D&A 2.7x CapEx10-K 2026-03-03, cash flow statement0.951.5
CEO severance doubled to 24 months (Feb 23, 2026)8-K 2026-02-260.951.0
Connaway CFO departed after 35 days; "unrelated to accounting"10-K 2026-03-03, management transition0.950.6
3 CFO transitions in 12 months10-K + 8-K timeline reconstruction0.950.5
All D&O own 0.6% of shares; zero open market purchasesDEF 14A 2025-04-23 + yfinance insider data0.900.6
Wasatch Advisors reduced from 3.8M to 2.6M shares (sole power)Schedule F/13G filings, Feb 2024 vs Feb 20250.900.7
Goodwill $498M = 33% of assets; qualitative impairment test only10-K 2026-03-03, Note 80.950.7
i3PD full goodwill impairment $25.9M in 2.5 years10-K 2026-03-03, Note 80.950.7
AGCO (Fendt/Valtra/MF) commonizing on Faster couplingsQ3 2025 transcript, Bagan line ≈930.751.4
Idiosyncratic variance 59% (below 75% target), IWM β=1.21iev regress, 250-day OLS0.850.9
EV/EBITDA 14.5x vs peer range 17-20x (20-30% discount)yfinance + scratchpad calculations0.851.5
2022-2024 LTI performance equity paid 0% at corporateDEF 14A 2025-04-23, compensation section0.951.0
HLIO tariff exposure: $133M US exports (16% of sales), China 11% of rev10-K 2026-03-03, risk factors0.950.8
Amortization declining: $30.5M (2026) → $25.3M (2029)10-K 2026-03-03, Note 8 intangibles schedule0.951.3
IDEX never mentions HLIO in 7 transcripts (15-year partnership)Transcript search, Q2 2024 - Q4 20250.800.8
Electronics CapEx halved: $8.6M (FY2023) → $4.3M (FY2025)10-K 2026-03-03, Note 160.950.7
Options: March 20 expiry = Investor Day; put IV +12.9% over call IVyfinance options chain, 2026-03-090.801.0
CEMA: European ag machinery orders expected to decline next 6 months10-K 2026-03-03, MD&A lines 2092-2103 (citing CEMA Dec 2025)0.900.6
Unnamed rec customer likely Polaris (Bagan's former employer, 23 yrs)Q4 transcript context + DEF 14A Bagan bio0.650.7
Electronics CapEx halved while segment guided +7% growth10-K 2026-03-03, Note 160.950.7